336065
Early Intervention Program for Adolescent Mothers: A Public Health Nurse Evidence-Based Model of Home Visiting – Lessons Learned
Description: In 2011 the Early Intervention Program for Adolescent Mothers (EIP) was designated an evidence-based model by DHHS, eligible for funding under MIECHV and the ACA. The EIP, a public health nurse (PHN) home visiting intervention, was evaluated in a randomized controlled trial (R01-NR02325). Two-year findings were significant on a number of important child and maternal measures. The EIP will be described.
Lessons Learned: Of the 17 models currently meeting DHHS criteria, two are primarily PHN models: the Nurse Family Partnership and the EIP. Without an existing infrastructure, the EIP is not able to compete nationally.
Implications/Recommendations: Important implications for promising home visiting programs include: rigorous and longitudinal evaluation criteria consistent with MIECHV benchmarks; disseminate findings beyond scientific literature, ensuring that state decision makers/gatekeepers to MIECHV funding are aware of your significant findings; need for replication/sustainability; advocating for infrastructure and replication funding, as these will be crucial for expansion of future promising EBMs.
Learning Areas:
Implementation of health education strategies, interventions and programsPublic health or related laws, regulations, standards, or guidelines
Public health or related nursing
Learning Objectives:
List potential obstacles for broader implementation of promising evidence based models of home visiting.
Identify strategies to enhance development and adoption of newer home visiting models.
Keyword(s): Maternal and Child Health, Nurses/Nursing
Qualified on the content I am responsible for because: I was the project director for the EIP R01 grant and considered one of the model developers.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.